Anti-DLL3 antibody drug conjugates
US9173959B1 · kind B1 · utility
3Cited by
46References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2015 |
| Grant date | Nov 3, 2015 |
| Priority date | — |
| Expiry date | Jul 23, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions to treat proliferative disorders are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.